Global Paraneoplastic Neurologic Syndrome Market, By Type (Limbic Encephalitis, Subacute Sensory Neuropathy, Cerebellar Degeneration, Lambert-Eaton Myasthenic Syndrome, Peripheral Nerve Hyperexcitability Syndrome), Treatment (Medication, Intravenous Immunoglobulin (IVIg), Plasmapheresis, Physical Therapy, Speech Therapy), Diagnosis (Blood tests, Lumbar Puncture, Imaging Tests, Others), Symptoms (Gait Disturbance, Decreased Muscle Tone, Decreased Speech Intelligibility, Dysphagia, Fine Motor Coordination, Visual Problems, Memory Loss, Dizziness, Sensory Deficits, Epileptic Seizures, Others), Dosage (Injection, Tablets, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2029
Market Analysis and Insights Global Paraneoplastic Neurologic Syndrome Market
Paraneoplastic neurologic syndrome market is expected to gain market growth in the forecast period of 2022-2029. Data Bridge Market Research analyses the market to account to grow at a CAGR of 5.80% in the above mentioned forecast period.
PNS (paraneoplastic neurological syndrome) is a rare neurological disease characterized by an aberrant immune system reaction that occurs in response to cancer. The word paraneoplastic refers to the fact that the neurological disease is induced by the tumor's immune reactions rather than the tumor itself. It primarily affects persons in their middle and old age. It is most commonly seen in people with malignancies of the lung, ovary, lymphatic system, and breast. Within days or weeks of a tumor diagnosis, neurological symptoms frequently appear. Gait disruption, decreased muscle tone, dysphagia, fine motor coordination, memory loss, dizziness, vision issues, poor speech intelligibility, sensory impairments, and epileptic seizures, among others are some of the symptoms seen with these syndromes.
The rise in the number of patients suffering from cancer including ovary, lung, lymphatic system, and breast cancer will act as major driver that will results in the expansion of market’s growth. Another significant factor influencing the growth rate of paraneoplastic neurologic syndrome market is the rising healthcare expenditure. Furthermore, advancement in the medical technology, rising initiatives by public and private organisations to spread awareness about rare diseases and growing government funding are the factors that will expand the paraneoplastic neurologic syndrome market. Other factors such as increase in the demand for effective therapies and rising geriatric population will positively impact the paraneoplastic neurologic syndrome market’s growth rate. Additionally, high disposable income and changing lifestyle will result in the expansion of paraneoplastic neurologic syndrome market.
Moreover, the rise in the research and development activities and launch of effective therapies will provide beneficial opportunities for the paraneoplastic neurologic syndrome market in the forecast period of 2022-2029. Also, high unmet need of current treatment and developments in healthcare technology will escalate the growth rate paraneoplastic neurologic syndrome market in future.
However, high cost associated with the treatment and lack of infrastructure in low-income countries will impede the growth rate of paraneoplastic neurologic syndrome market. Additionally, complications involved with paraneoplastic neurologic syndrome will hinder the paraneoplastic neurologic syndrome market growth. Less awareness will further challenge the market in the forecast period mentioned above.
This paraneoplastic neurologic syndrome market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Paraneoplastic neurologic syndrome market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Paraneoplastic Neurologic Syndrome Market Scope and Market Size
The paraneoplastic neurologic syndrome market is segmented on the basis of type, treatment, diagnosis, symptoms, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of type, the paraneoplastic neurologic syndrome market is segmented into limbic encephalitis, subacute sensory neuropathy, cerebellar degeneration, lambert-eaton myasthenic syndrome and peripheral nerve hyperexcitability syndrome
- On the basis of treatment, the paraneoplastic neurologic syndrome market is segmented into medication, intravenous immunoglobulin (IVIg), plasmapheresis, physical therapy, and speech therapy. The medication segment is further sub-segmented into immunosuppressants, corticosteroids, anticonvulsant drugs and others. Others are divided into medication used to enhance nerve-to-muscle transmission which further involves pyridostigmine.
- On the basis of diagnosis, the paraneoplastic neurologic syndrome market is segmented into blood tests, lumbar puncture, imaging tests and others. The segment of imaging tests is further sub-segmented into magnetic resonance imaging (MRI), computed tomography (CT) scan, positron emission tomography (PET), and PET plus CT.
- On the basis of symptoms, the paraneoplastic neurologic syndrome market is segmented into fatigue, tenderness, fever, nausea and vomiting, abdominal pain in the upper-right region, swelling of the abdomen, persistent itching, brown urine, jaundice, clay-coloured stool, pain and others.
- On the basis of dosage, the paraneoplastic neurologic syndrome market is segmented into injection, tablets and others.
- On the basis of route of administration, the paraneoplastic neurologic syndrome market is segmented into oral, parenteral and others.
- On the basis of end-users, the paraneoplastic neurologic syndrome market is segmented into clinic, hospital and others.
The paraneoplastic neurologic syndrome market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.
Paraneoplastic Neurologic Syndrome Market Country Level Analysis
Paraneoplastic neurologic syndrome market is analyzed and market size information is provided by the country, type, treatment, diagnosis, symptoms, dosage, route of administration, end-users and distribution channel as referenced above.
The countries covered in the paraneoplastic neurologic syndrome market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the paraneoplastic neurologic syndrome market due to the presence of major key players, high disposable income and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2022-2029 due to the increasing patient pool, rising investment in the healthcare sector, and growing government support.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Paraneoplastic neurologic syndrome market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Global Paraneoplastic Neurologic Syndrome Market Share Analysis
Paraneoplastic neurologic syndrome market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to paraneoplastic neurologic syndrome market research.
Some of the major players operating in the paraneoplastic neurologic syndrome market are F. Hoffmann-La Roche Ltd., Glenmark Pharmaceuticals Limited, Novartis AG, AstraZeneca, Johnson & Johnson Private Limited, AbbVie Inc., Bristol-Myers Squibb Company, Pfizer Inc., Sanofi, Aurobindo Pharma, Mylan N.V., GlaxoSmithKline plc, Cipla Inc., Sun Pharmaceutical Industries Ltd., Abbott, Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., UCB S.A., Sunovion Pharmaceuticals Inc., GW Pharmaceuticals plc., Takeda Pharmaceutical Company Limited., Sumitomo Dainippon Pharma Co., Ltd., Biocon, Merck KGaA, and LEO Pharma A/S, among others.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.